Parkinson's disease mortality and socioeconomic status: New information from a Korean study

2020 ◽  
Vol 80 ◽  
pp. 212-213
Author(s):  
Hélio A.G. Teive ◽  
Joohi Jimenez-Shahed
2017 ◽  
Vol 2017 ◽  
pp. 1-8 ◽  
Author(s):  
Lucio Marinelli ◽  
Carlo Trompetto ◽  
Stefania Canneva ◽  
Laura Mori ◽  
Flavio Nobili ◽  
...  

Learning new information is crucial in daily activities and occurs continuously during a subject’s lifetime. Retention of learned material is required for later recall and reuse, although learning capacity is limited and interference between consecutively learned information may occur. Learning processes are impaired in Parkinson’s disease (PD); however, little is known about the processes related to retention and interference. The aim of this study is to investigate the retention and anterograde interference using a declarative sequence learning task in drug-naive patients in the disease’s early stages. Eleven patients with PD and eleven age-matched controls learned a visuomotor sequence, SEQ1, during Day1; the following day, retention of SEQ1 was assessed and, immediately after, a new sequence of comparable complexity, SEQ2, was learned. The comparison of the learning rates of SEQ1 on Day1 and SEQ2 on Day2 assessed the anterograde interference of SEQ1 on SEQ2. We found that SEQ1 performance improved in both patients and controls on Day2. Surprisingly, controls learned SEQ2 better than SEQ1, suggesting the absence of anterograde interference and the occurrence of learning optimization, a process that we defined as “learning how to learn.” Patients with PD lacked such improvement, suggesting defective performance optimization processes.


2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Michal Dufek ◽  
Irena Rektorova ◽  
Vojtech Thon ◽  
Jindrich Lokaj ◽  
Ivan Rektor

Objectives. The association between abnormal serum immunomarkers and mortality in 53 consecutive Parkinson’s disease patients was studied.Materials and Methods. The plasma level of specific inflammatory cytokines was investigated: mannan-binding lectin (MBL), interleukin- (IL-) 6, and tumor necrosis factor-alpha (TNF-α). The baseline serum immunomarkers obtained from patients who died (n=16) during a four-year follow-up period were compared with the data of patients who survived (n=37).Results. The baseline level of IL-6 was significantly higher in the deceased patients than in the survivors. Elevated IL-6 levels and age were major independent contributors to disease mortality. Differences between other plasma cytokine level abnormalities were not significant.Conclusion. This study showed that IL-6 elevation may be a marker of increased mortality risk in Parkinson’s disease patients. The inflammation may act in association with other factors and comorbidities in progressive neurodegenerative pathology.


2015 ◽  
Vol 72 (6) ◽  
pp. 448-455 ◽  
Author(s):  
Maartje Brouwer ◽  
Tom Koeman ◽  
Piet A van den Brandt ◽  
Hans Kromhout ◽  
Leo J Schouten ◽  
...  

2013 ◽  
Vol 19 (5) ◽  
pp. 515-521 ◽  
Author(s):  
Robert Caslake ◽  
Kate Taylor ◽  
Neil Scott ◽  
Joanna Gordon ◽  
Clare Harris ◽  
...  

2005 ◽  
Vol 20 (12) ◽  
pp. 1614-1617 ◽  
Author(s):  
Chava Peretz ◽  
Bruce H. Alexander ◽  
Sonia I. Nagahama ◽  
Karen B. Domino ◽  
Harvey Checkoway

Sign in / Sign up

Export Citation Format

Share Document